Clinical Trials
10 trialsNCT06058377 2026-05-27
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Recruiting
NCT05649072 2026-05-22
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT07091617 2026-05-11
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Alliance for Clinical Trials in Oncology
Phase NA Recruiting
NCT05676099 2026-05-08
TSC Biosample Repository and Natural History Database
National Tuberous Sclerosis Association
Recruiting
NCT06632977 2026-05-08
PREDICT
Alliance for Clinical Trials in Oncology
Phase 2 Recruiting
NCT06008392 2026-04-07
INTERCEPTioN
Mayo Clinic
Recruiting
NCT04475640 2026-04-02
Cancer Genetic Testing in Ethnic Populations
Mayo Clinic
Phase NA Recruiting
NCT07498829 2026-03-27
PROTECT-C
Queen Mary University of London
Phase NA Recruiting
NCT03897374 2026-03-19
STOP-Cancer
ClinLogic LLC
Recruiting
NCT01772771 2026-03-03
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
M.D. Anderson Cancer Center
Recruiting